Criminal Code Act 1995
Schedule
-
The Criminal Code
Division 314
-
(Repealed by No 167 of 2012)
SECTION 314.3
Controlled precursors
(1)
The following table lists controlled precursors and sets out quantities:
(2)
A substance is a controlled precursor if the substance is a salt or ester of a precursor listed in the table in subsection (1).
Section 3
CHAPTER 9 - DANGERS TO THE COMMUNITY Part 9.1 - Serious drug offences
View history note
Hide history noteHistory
Pt 9.1 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
History
Div 314 repealed by No 167 of 2012, s 3 and Sch 1 item 19, applicable in relation to offences against Part 9.1 of the Criminal Code that are committed on or after 29 May 2013. Div 314 formerly read:
Division 314 - Drugs, plants, precursors and quantities
SECTION 314.1 Controlled drugs
(1)
The following table lists controlled drugs and sets out quantities:
Controlled drugs and quantities Controlled drug Trafficable Marketable Commercial quantity quantity quantity (grams) (grams) (kilograms) 1 Amphetamine 2.0 250.0 0.75 1A Benzylpiperazine (BZP) 2.0 250.0 0.75 2 Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre) 250.0 25,000.0 125.0 3 Cannabis resin 20.0 25,000.0 125.0 4 Cocaine 2.0 250.0 2.0 5 Gammabutyrolactone (GBL) 0.5 250.0 1.0 6 4-Hydroxybutanoic acid (GHB) 0.5 250.0 1.0 7 Heroin (diacetylmorphine) 2.0 250.0 1.5 7A Ketamine 3.0 500.0 1.0 8 Lysergide (LSD) 0.002 0.05 0.002 9 Methamphetamine 2.0 250.0 0.75 9A Methcathinone 2.0 250.0 0.75 10 3,4-Methylenedioxyamphetamine (MDA) 0.5 100.0 0.75 11 3,4-Methylenedioxymethamphetamine (MDMA) 0.5 100.0 0.5 11A 4-Methylmethcathinone (4-MMC) 2.0 250.0 0.75 12 Opium 20.0 10,000.0 20.0 13 Psilocine 2.0 1,000.0 2.0 14 Psilocybine 2.0 1,000.0 2.0 15 Tetrahydrocannabinol (THC) 2.0 1,000.0 5.0 HistoryS 314.1(1) amended by No 24 of 2012, s 3 and Sch 5 items 1 - 4, by inserting table items 1A, 7A, 9A and 11A, effective 4 April 2012.
(2)
A substance is a controlled drug if the substance (the drug analogue ) is, in relation to a controlled drug listed in subsection (1) (or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a controlled drug):
(a) a stereoisomer; or
(b) a structural isomer having the same constituent groups; or
(c) an alkaloid; or
(d) a structural modification obtained by the addition of one or more of the following groups:
(i) alkoxy, cyclic diether, acyl, acyloxy, mono-amino or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;
(ii) alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;
(iii) halogen, hydroxy, nitro or amino groups; or
(e) a structural modification obtained in one or more of the following ways:
(i) by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;
(ii) by the addition of hydrogen atoms to one or more unsaturated bonds;
(iii) by the replacement of one or more of the groups specified in paragraph (d) with another such group or groups;
(iv) by the conversion of a carboxyl or an ester group into an amide group; or
(f) otherwise a homologue, analogue, chemical derivative or substance substantially similar in chemical structure;however obtained, except where the drug analogue is separately listed in subsection (1).
(3)
The trafficable quantity for a drug analogue described in subsection (2) is:
(a) unless paragraph (b) applies - the trafficable quantity set out in the table in subsection (1) for the controlled drug to which the drug analogue relates (whether directly or indirectly); or
(b) if the drug analogue relates to more than one controlled drug listed in the table in subsection (1) - the smallest trafficable quantity set out in the table in subsection (1) for any of those controlled drugs.
(4)
The marketable quantity for a drug analogue described in subsection (2) is:
(a) unless paragraph (b) applies - the marketable quantity set out in the table in subsection (1) for the controlled drug to which the drug analogue relates (whether directly or indirectly); or
(b) if the drug analogue relates to more than one controlled drug listed in the table in subsection (1) - the smallest marketable quantity set out in the table in subsection (1) for any of those controlled drugs.
(5)
The commercial quantity for a drug analogue described in subsection (2) is:
(a) unless paragraph (b) applies - the commercial quantity set out in the table in subsection (1) for the controlled drug to which the drug analogue relates (whether directly or indirectly); or
(b) if the drug analogue relates to more than one controlled drug listed in the table in subsection (1) - the smallest commercial quantity set out in the table in subsection (1) for any of those controlled drugs.HistoryS 314.1 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 314.2 SECTION 314.2 Controlled plants
314.2
The following table lists controlled plants and set out quantities:
Controlled plants and quantities Controlled plant Trafficable Marketable Commercial quantity quantity quantity 1 Any plant of the genus Cannabis 250 g or 10 plants 25 kg or 100 plants 250 kg or 1,000 plants SECTION 314.3 Controlled precursorsHistoryS 314.2 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
(1)
The following table lists controlled precursors and sets out quantities:
Controlled precursors and quantities Controlled precursor Marketable Commercial quantity quantity (grams) (kilograms) 1 Ephedrine 400.0 1.2 2 Ergometrine 0.15 0.006 3 Ergotamine 0.25 0.01 4 Isosafrole 290.0 1.45 5 Lysergic acid 0.075 0.003 6 3,4-Methylenedioxyphenylacetic acid 300.0 1.5 7 3,4-Methylenedioxyphenyl-2-propanone 150.0 0.75 8 Phenylacetic acid 1,350.0 4.05 8A Phenylpropanolamine 400.0 1.2 9 Phenyl-2-propanone 675.0 2.03 10 Piperonal 320.0 1.6 11 Pseudoephedrine 400.0 1.2 12 Safrole 570.0 2.85 HistoryS 314.3(1) amended by No 24 of 2012, s 3 and Sch 5 item 5, by inserting table item 8A, effective 4 April 2012.
(2)
A substance is a controlled precursor if the substance is a salt or ester of a precursor listed in the table in subsection (1).HistoryS 314.3 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 314.4 Border controlled drugs
(1)
The following table lists border controlled drugs and sets out quantities:
Controlled precursors and quantities Controlled precursor Marketable Commercial quantity quantity (grams) (grams) 1 Acetorphine 2.0 2.0 2 Acetyl-alpha-methylfentanyl 0.005 0.005 3 Acetylcodeine 2.0 2.0 4 Acetyldihydrocodeine 2.0 2.0 5 Acetylmethadol 2.0 2.0 6 Allylprodine 2.0 2.0 7 Alphacetylmethadol 10.0 10.0 8 Alphameprodine 0.2 0.2 9 Alphamethadol 0.2 0.2 10 alpha-Methylfentanyl 0.005 0.005 11 alpha-Methylthiofentanyl 0.005 0.005 12 Alphaprodine 25.0 25.0 13 Amphecloral 2.0 2.0 14 3-(2-Aminopropyl)indole (alpha-methyltryptamine (AMT)) 2.0 2.0 15 Amphetamine 2.0 0.75 16 Anileridine 25.0 25.0 17 Barbiturates 50.0 5.0 18 Benzethidine 10.0 10.0 19 Benzoylecgonine 2.0 2.0 20 Benzylmorphine 5.0 5.0 20A Benzylpiperazine (BZP) 2.0 0.75 21 Betacetylmethadol 5.0 5.0 22 beta-Hydroxyfentanyl 0.005 0.005 23 beta-Hydroxy-3-methylfentanyl 0.005 0.005 24 Betameprodine 5.0 5.0 25 Betamethadol 5.0 5.0 26 Betaprodine 5.0 5.0 27 Bezitramide 5.0 5.0 28 4-Bromo-2,5-dimethoxy amphetamine 0.5 0.5 29 Bufotenine 2.0 2.0 30 Cannabinoids (other than a Cannabinoid of a kind that can be obtained from a plant that is not a Cannabis plant) 2.0 2.0 31 Cannabis (in any form, including flowering or fruiting tops, leaves, seeds or stalks, but not including Cannabis resin or Cannabis fibre) 25,000.0 100.0 32 Cannabis resin 20.0 50.0 33 Chlorophentermine 2.0 2.0 34 Clonitazene 5.0 5.0 35 Cocaine 2.0 2.0 36 Codeine 10.0 10.0 37 Codeine-N-oxide 10.0 10.0 38 Codoxime 10.0 10.0 39 Desomorphine 2.0 2.0 40 Dexamphetamine 2.0 2.0 41 Dextromoramide 2.0 2.0 42 2,5-Dimethoxy-4-n-propylthiophenethylamine (2C-T-7) 0.5 0.5 43 2,5-Dimethoxy-4-ethylthiophenethylamine (2C-T-2) 0.5 0.5 44 2,5-Dimethoxy-4-iodophenethylamine (2C-I) 0.5 0.5 45 Diampromide 5.0 5.0 46 Diethylpropion 5.0 5.0 47 Diethylthiambutene 5.0 5.0 48 N,N-Diethyltryptamine 2.0 2.0 49 Difenoxin 2.0 2.0 50 Dihydrocodeine 10.0 10.0 51 Dihydromorphine 10.0 10.0 52 Dimenoxadol 10.0 10.0 53 Dimepheptanol 10.0 10.0 54 2,5-Dimethoxy-4-methyl amphetamine 2.0 0.75 55 1-Dimethylamino-1,2-diphenyl ethane 5.0 5.0 56 Dimethylthiambutene 20.0 20.0 57 N,N-Dimethyltryptamine 2.0 2.0 58 Dioxaphetyl butyrate 2.0 2.0 59 Diphenoxylate 2.0 2.0 60 Dipipanone 10.0 10.0 61 Drotebanol 2.0 2.0 62 Ecgonine 10.0 10.0 63 Ethchlorvynol 50.0 50.0 64 Ethinamate 50.0 50.0 65 Ethylmethylthiambutene 10.0 10.0 66 Ethylmorphine 2.0 2.0 67 Etonitazene 5.0 5.0 68 Etorphine 5.0 5.0 69 Etoxeridine 5.0 5.0 70 Fentanyl 0.005 0.005 71 Furethidine 1.0 1.0 72 Gammabutyrolactone (GBL) 2.0 1.0 73 Glutethimide 50.0 50.0 74 Harmaline 2.0 5.0 75 Harmine 2.0 5.0 76 Heroin (diacetylmorphine) 2.0 1.5 77 Hydrocodone 2.0 2.0 78 Hydromorphinol 2.0 2.0 79 Hydromorphone 2.0 2.0 80 Hydroxyamphetamine 2.0 2.0 81 4-Hydroxybutanoic acid (GHB) 2.0 1.0 82 Hydroxypethidine 5.0 5.0 83 Isomethadone 2.0 2.0 83A Ketamine 3.0 1.0 84 Ketobemidone 2.0 2.0 85 Levophenacylmorphan 2.0 2.0 86 Levomethorphan, but not including dextromethorphan 2.0 2.0 87 Levorphanol, but not including dextrorphan 1.0 1.0 88 Lysergamide 0.1 0.01 89 Lysergide (LSD) 0.002 0.002 90 Meprobamate 50.0 50.0 91 Mescaline 7.5 7.5 92 Metazocine 7.0 7.0 93 Methadone 2.0 2.0 93A Methamphetamine 2.0 0.75 94 Methaqualone 50.0 5.0 95 Methcathinone 2.0 0.75 96 Methorphan, but not including dextromethorphan 2.0 2.0 97 5-Methoxy-alpha-methyltrypt amine (5-MeO-AMT) 2.0 2.0 98 5-Methoxy-N,N-diisopropyl tryptamine (5-MeO-DiPT) 2.0 2.0 99 (Repealed by No 24 of 2012) 100 3,4-Methylenedioxyamphetamine (MDA) 0.5 0.75 101 3,4-Methylenedioxymethamphet amine (MDMA) 0.5 0.5 102 Methyldesorphine 2.0 2.0 103 Methyldihydromorphine 2.0 2.0 104 3-Methylfentanyl 0.005 0.005 104A 4-Methylmethcathinone (4-MMC) 2.0 0.75 105 Methylphenidate 2.0 2.0 106 1-Methyl-4-phenyl-4-propion oxypiperidine (MPPP) 2.0 2.0 107 3-Methylthiofentanyl 0.005 0.005 108 Methyprylon 50.0 50.0 109 Metopon 2.0 2.0 110 Monoacetylmorphines 2.0 2.0 111 Moramide 2.0 2.0 112 Morphan, but not including dextrorphan 2.0 2.0 113 Morpheridine 2.0 2.0 114 Morphine 2.0 1.5 115 Morphine-N-oxide 2.0 2.0 116 Myrophine 20.0 20.0 117 Nicocodine 2.0 2.0 118 Nicodicodine 2.0 2.0 119 Nicomorphine 2.0 2.0 120 Noracymethadol 2.0 2.0 121 Norcodeine 2.0 2.0 122 Norlevorphanol 2.0 2.0 123 Normethadone 5.0 5.0 124 Normorphine 20.0 20.0 125 Norpipanone 10.0 10.0 126 Opium 20.0 20.0 127 Oxycodone 5.0 5.0 128 Oxymorphone 2.0 2.0 129 para-Fluorofentanyl 0.005 0.005 130 Pentazocine 20.0 20.0 131 Pethidine 10.0 10.0 132 Phenadoxone 10.0 10.0 133 Phenampromide 10.0 10.0 134 Phenazocine 1.0 1.0 135 Phencyclidine 2.0 2.0 136 Phendimetrazine 5.0 5.0 137 Phenmetrazine 5.0 5.0 138 Phenomorphan 5.0 5.0 139 Phenoperidine 1.0 1.0 140 Phentermine 5.0 5.0 141 1-Phenylethyl-4-phenyl-4-ace toxypiperidine (PEPAP) 2.0 2.0 142 Pholcodine 5.0 5.0 143 Piminodine 10.0 10.0 144 Pipradrol 1.0 1.0 145 Piritramide 1.0 1.0 146 Proheptazine 1.0 1.0 147 Properidine 25.0 25.0 148 Propiram 10.0 10.0 149 Psilocine 0.1 0.1 150 Psilocybine 0.1 0.1 151 Tetrahydrocannabinols 2.0 5.0 152 Thebacon 2.0 2.0 153 Thebaine 2.0 2.0 154 Thiofentanyl 0.005 0.005 155 Trimeperidine 10.0 10.0 HistoryS 314.4(1) amended by No 24 of 2012, s 3 and Sch 5 items 6 - 11, by inserting table items 20A, 83A, 93A and 104A, substituting table item 95 and repealing table item 99, effective 4 April 2012. Table items 95 and 99 formerly read:
95 Methcathinone 99 Methamphetamine 2.0 0.75
(2)
A substance is also a border controlled drug if the substance (the drug analogue ) is, in relation to a border controlled drug listed in subsection (1) (or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a border controlled drug):
(a) a stereoisomer; or
(b) a structural isomer having the same constituent groups; or
(c) an alkaloid; or
(d) a structural modification obtained by the addition of one or more of the following groups:
(i) alkoxy, cyclic diether, acyl, acyloxy, mono-animo or dialkylamino groups with up to 6 carbon atoms in any alkyl residue;
(ii) alkyl, alkenyl or alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon;
(iii) halogen, hydroxy, nitro or amino groups; or
(e) a structural modification obtained in one or more of the following ways:
(i) by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;
(ii) by the addition of hydrogen atoms to one or more unsaturated bonds;
(iii) by the replacement of one or more of the groups specified in paragraph (d) with another such group or groups;
(iv) by the conversion of a carboxyl or an ester group into an amide group; or
(f) otherwise a homologue, analogue, chemical derivative or substance substantially similar in chemical structure;however obtained, except where the drug analogue is separately listed in subsection (1).
(3)
The marketable quantity for a drug analogue described in subsection (2) is:
(a) unless paragraph (b) applies - the marketable quantity specified in the table in subsection (1) for the border controlled drug to which the drug analogue relates (whether directly or indirectly); or
(b) if the drug analogue relates to more than one border controlled drug listed in the table in subsection (1) - the smallest marketable quantity specified in the table in subsection (1) for any of those border controlled drugs.
(4)
The commercial quantity for a drug analogue described in subsection (2) is:
(a) unless paragraph (b) applies - the commercial quantity specified in the table in subsection (1) for the border controlled drug to which the drug analogue relates (whether directly or indirectly); or
(b) if the drug analogue relates to more than one border controlled drug listed in the table in subsection (1) - the smallest commercial quantity specified in the table in subsection (1) for any of those border controlled drugs.HistoryS 314.4 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
SECTION 314.5 SECTION 314.5 Border controlled plants
314.5
The following table lists border controlled plants and sets out quantities:
Border controlled plants and quantities Border controlled precursor Marketable Commercial quantity quantity 1 Any plant of the genus Cannabis 25 kg or 100 plants 250 kg or 1,000 plants 2 Any plant of the genus Erythroxylon (also known as Erythroxylum) from which cocaine can be extracted either directly or by chemical transformation 80 kg 3 Any plant of the genus Lophophora 4 Any plant of the species Papaver bracteatum 10 kg 5 Any plant of the species Papaver somniferum 10 kg 6 Any plant of the species Piptagenia peregrine 7 Any plant of the species Psilocybe S 314.5 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
(1)
The following table lists border controlled precursors and sets out quantities:
Border controlled precursors and quantities Border controlled precursors Marketable Commercial quantity quantity (grams) (kilograms) 1 N-Acetylanthranilic acid 2 Any plant of the species Ephedra 3 Ephedrine 3.2 1.2 4 Ergometrine 0.006 0.006 5 Ergotamine 0.01 0.01 6 Isosafrole 1.45 1.45 7 Lysergic acid 0.003 0.003 8 3,4-Methylenedioxyphenyl-2-propanone 0.75 0.75 9 Phenylacetic acid 10.8 4.05 10 Phenylpropanolamine 3.2 1.2 11 Phenyl-2-propanone 5.4 2.03 12 Piperonal 1.6 1.6 13 Pseudoephedrine 3.2 1.2 14 Safrole 2.85 2.85 HistoryS 314.6(1) amended by No 24 of 2012, s 3 and Sch 5 item 12, by substituting table item 10, effective 4 April 2012. Table item 10 formerly read:
10 Phenylpropanolamine
(2)
A substance is a border controlled precursor if the substance is a salt or ester of a precursor listed in the table in subsection (1).
(3)
A substance is a border controlled precursor if the substance is a chemical or compound, other than a chemical or compound that is listed in a table in this Division, that, in the manufacture by a chemical process of a chemical or compound referred to in the table in subsection (1), is an immediate precursor of that chemical or compound.HistoryS 314.6 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
Div 314 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
The following table lists controlled precursors and sets out quantities:
| Controlled precursors and quantities | ||
| Controlled precursor | Marketable | Commercial |
| quantity | quantity | |
| (grams) | (kilograms) | |
| 1 Ephedrine | 400.0 | 1.2 |
| 2 Ergometrine | 0.15 | 0.006 |
| 3 Ergotamine | 0.25 | 0.01 |
| 4 Isosafrole | 290.0 | 1.45 |
| 5 Lysergic acid | 0.075 | 0.003 |
| 6 3,4-Methylenedioxyphenylacetic acid | 300.0 | 1.5 |
| 7 3,4-Methylenedioxyphenyl-2-propanone | 150.0 | 0.75 |
| 8 Phenylacetic acid | 1,350.0 | 4.05 |
| 8A Phenylpropanolamine | 400.0 | 1.2 |
| 9 Phenyl-2-propanone | 675.0 | 2.03 |
| 10 Piperonal | 320.0 | 1.6 |
| 11 Pseudoephedrine | 400.0 | 1.2 |
| 12 Safrole | 570.0 | 2.85 |
History
S 314.3(1) amended by No 24 of 2012, s 3 and Sch 5 item 5, by inserting table item 8A, effective 4 April 2012.
(2)
A substance is a controlled precursor if the substance is a salt or ester of a precursor listed in the table in subsection (1).
History
S 314.3 inserted by No 129 of 2005, s 3 and Sch 1 item 1, effective 6 December 2005.
Disclaimer and notice of copyright applicable to materials provided by CCH Australia Limited
CCH Australia Limited ("CCH") believes that all information which it has provided in this site is accurate and reliable, but gives no warranty of accuracy or reliability of such information to the reader or any third party. The information provided by CCH is not legal or professional advice. To the extent permitted by law, no responsibility for damages or loss arising in any way out of or in connection with or incidental to any errors or omissions in any information provided is accepted by CCH or by persons involved in the preparation and provision of the information, whether arising from negligence or otherwise, from the use of or results obtained from information supplied by CCH.
The information provided by CCH includes history notes and other value-added features which are subject to CCH copyright. No CCH material may be copied, reproduced, republished, uploaded, posted, transmitted, or distributed in any way, except that you may download one copy for your personal use only, provided you keep intact all copyright and other proprietary notices. In particular, the reproduction of any part of the information for sale or incorporation in any product intended for sale is prohibited without CCH's prior consent.
